← Back to Search

Educational Messages for Vaping Behavior

N/A

Waitlist Available

Research Sponsored by University of Georgia

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 month

Awards & highlights

Study Summary

This trial will study the effect of vaping on 60 young African Americans, using baseline fMRI and 4 weekly surveys to assess nicotine use and response to anti-vaping PSAs.

Who is the study for?

This trial is for African American young adults aged 18-29 who vape but haven't smoked cigarettes in the past month. Participants must have used a vaping device at least once in the last 30 days and be safe to undergo MRI scans. Those with major health disorders or outside the age range are excluded.Check my eligibility

What is being tested?

The study examines how anti-vaping public service announcements affect brain activity and tobacco use behavior among vapers, using fMRI neuroimaging and follow-up surveys over four weeks to track changes.See study design

What are the potential side effects?

There are no direct side effects from participating in this trial as it involves non-invasive fMRI scanning and exposure to educational messages, rather than medication or medical procedures.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 month

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 month

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Self-report smoking severity in the following month

Self-report vaping intention

Self-report vaping severity in the following month

Secondary outcome measures

Message effectiveness perceptions

Self-report other substance use severity in the following month

Self-report other tobacco use severity in the following month

Trial Design

1Treatment groups

Experimental Treatment

Group I: Message exposureExperimental Treatment1 Intervention

Participants will all be exposed to anti-vaping PSAs utilizing cognitive, emotional, and social appeals, aiming to persuade them to reduce or quit using e-cigarettes.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of GeorgiaLead Sponsor

100 Previous Clinical Trials

34,598 Total Patients Enrolled

Media Library

Message exposure Clinical Trial Eligibility Overview. Trial Name: NCT05829863 — N/A

Sunburn Research Study Groups: Message exposure

Sunburn Clinical Trial 2023: Message exposure Highlights & Side Effects. Trial Name: NCT05829863 — N/A

Message exposure 2023 Treatment Timeline for Medical Study. Trial Name: NCT05829863 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are senior citizens being included in the research cohort of this investigation?

"The lower and upper age limits for enrolment in this trial are 18 and 29 respectively, as outlined in the requirements for eligibility."

Answered by AI

What criteria must be met to qualify for participation in this research?

"In order to be accepted into the study, candidates must have a sunburn and should fall within 18-29 years of age. This particular clinical trial is currently targeting 60 participants."

Answered by AI

Are there any open slots for new participants in this clinical trial?

"According to clinicaltrials.gov, this particular clinical trial has ceased recruitment of participants. Initially posted on the 5th May 2023 and last amended on the 13th April 2023, there are presently 1 other trials enrolling patients at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A Neuroimaging Approach to Advance Mechanistic Understanding of Tobacco Use Escalation Risk Among Young Adult African American Vapers

Jiaying Liu 2023. "A Neuroimaging Approach to Advance Mechanistic Understanding of Tobacco Use Escalation Risk Among Young Adult African American Vapers". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05829863.